Bringing the fundamentals into focus…
Back to BioMarin Pharmaceutical Inc.
How BioMarin Pharmaceutical Inc. stacks up
BMRN · against 557 other Healthcare companies listed in US-listed
Profitability
41/ 100
Above the middle of the pack.
Ranked #210 of 558 · scores higher than 61% of peers
Bars: peers in each 10-point band of the profitability score33 peers with a profitability score of 40–49, including BMRN · Click a bar to see the companies
Why profitability scores 41?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- a lower return on invested capital: weaker than 61% of peers. Return on invested capital: 1.2% vs peer median 4.7%
- Operating margin is close to the peer norm. Operating margin: 4.4% vs peer median 7.1%
- Return on assets is close to the peer norm. Return on assets: 0.6% vs peer median 1.7%
Metric by metric
Position: dot = BMRN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BMRN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | 1.2% | -7.0% | 58% | 33% | |
| Operating marginHigher is better · 479 reported | 4.4% | -2.4% | 60% | 33% | |
| Return on assetsHigher is better · 582 reported | 0.6% | -7.8% | 63% | 33% | |
| Return on equityHigher is better · 531 reported | 1.2% | -19.7% | 64% | Context only | |
| Gross marginHigher is better · 601 reported | 51.0% | 43.9% | 55% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around BMRN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 207 | 1.1B USD | 42 | 43 | |
| 207 | 1.5B USD | 42 | 59 | |
| 210 | 1.2B USD | 41 | 42 | |
| 210 | 17M USD | 41 | 16 | |
| 210 | 10.8B USD | 41 | 41 | |
| 210 | 15.7B USD | 41 | 33 | |
| 210 | 4.0B USD | 41 | 46 | |
| 210 | 10.8B USD | 41 | 35 | |
| 210 | 3.1B USD | 41 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score